Table 2. HRs for microRNAs.
Study | miRNA | Sample size | OS | DFS | RFS | Expression associates with poor prognosis | ||||
---|---|---|---|---|---|---|---|---|---|---|
High level | Low level | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |||
Luo 2015 | miR-26b | 32 | 56 | 0.388 (0.355-0.727) | 0.007 | - | - | 0.475 (0.311-0.573) | 0.013 | Low |
Safari 2015 | miR-20a | 24 | 16 | 2.47 (1.31-4.66) | 0.005 | - | - | - | - | High |
miR-10a | 24 | 16 | 2.35 (1.23-4.50) | 0.01 | - | - | - | - | High | |
Wang C 2015 | miR-335 | 59 | 79 | 0.251 (0.095-0.663) | 0.005 | - | - | 0.66 (0.47-0.92) | 0.015 | Low |
Wang Q 2015 | miR-145 | 51 | 63 | 0.63 (0.54-0.83) | 0.008 | - | - | - | - | Low |
He 2014 | miR-107 | 31 | 42 | 1.48 (0.93-2.35) | 0.1005 | 1.89 (1.19-3.00) | 0.0073 | - | - | High |
miR-130a | 33 | 40 | 1.38 (0.87-2.19) | 0.1723 | 1.74 (1.10-2.77) | 0.018 | - | - | High | |
Liang 2014 | miR-215 | 199 | 136 | - | - | 0.49 (0.28-0.86) | 0.013 | - | - | Low |
Ma 2014 | miR-205 | 30 | 30 | 0.33 (0.14-0.76) | 0.009 | - | - | - | - | Low |
Park 2014 | miR-363-3p | 27 | 18 | 0.1 (0.0-0.4) | 0.006 | - | - | - | - | Low |
Wang 2014 | miR-31 | 27 | 27 | 1.482 (1.081-2.037) | 0.036 | - | - | - | - | High |
Yang 2014 | miR-126 | 71 | 62 | 0.252 (0.049-0.498) | 0.003 | - | - | - | - | Low |
Luo 2013 | miR-497 | 26 | 34 | 0.498 (0.332-0.743) | 0.0167 | 0.64 (0.38-1.06) | 0.085 | - | - | Low |
Shen 2013 | miR-224 | 66 | 60 | 1.59 (1.12-2.26) | 0.009 | - | - | - | - | High |
Huang 2012 | miR-125b | 4 | 40 | 0.352 (0.102-1.014) | 0.057 | - | - | - | - | Low |
miR-100 | 10 | 34 | 0.161 (0.036-0.814) | 0.044 | - | - | - | - | Low | |
miR-143 | 30 | 14 | 0.55(0.29-1.04) | 0.064 | - | - | - | - | Low | |
miR-145 | 26 | 18 | 0.58(0.32-1.05) | 0.072 | - | - | - | - | Low | |
miR-199a-5p | 24 | 20 | 0.56(0.31-1.01) | 0.056 | - | - | - | - | Low |
HR: hazard ratio; 95% CI: 95% confidence interval; OS: overall survival; RFS: recurrence-free survival; DFS: disease-free survival; -: no reported.